http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2244598-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9237fdf6dca9ac365fc5166858e7862 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D515-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D291-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D515-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-00 |
| filingDate | 2001-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ce80dcfe3034f92341a45e608a1f9d9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_394a00507a7cd58f77661cb950d38af5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0edcac8a1fa140f69bc64be703f1fb30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0596be321cb2979c06d105823138e1dc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c1579b0a29397aad6b023b0d3d89857 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c32f680e4b1d1137c0e1b586dbd1ef8 |
| publicationDate | 2005-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2244598-T3 |
| titleOfInvention | ECTEINASCIDINE ANTITUMOR DERIVATIVES. |
| abstract | A compound of the formula: the substituent groups defined by R1, R2 are each independently selected from H, C (= O) R¿, substituted or unsubstituted C1-C18 alkyl, C2-C18 alkenyl substituted or unsubstituted, substituted or unsubstituted C2-C18 alkynyl, substituted or unsubstituted aryl; Each of the groups R ¿is independently selected from the group consisting of H, OH, NO2, NH2, SH, CN, halogen, = O, C (= O) H, C (= O) CH3, CO2 H, substituted or unsubstituted C1-C18 alkyl, substituted or unsubstituted C2-C18 alkenyl, substituted or unsubstituted C2-C18 alkynyl, substituted or unsubstituted aryl; X2 is OX1 or N (X1) 2 where the or each of the X1 is independently H, C (= O) R ¿, where R¿ is as defined, C1-C18 alkyl substituted or not substituted, substituted or unsubstituted C2-C18 alkenyl, substituted or unsubstituted C2-C18 alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted alkoxy, substituted or unsubstituted heterocyclyl or two X1 groups may together form a cyclic substituent in the nitrogen atom, or X1 can be SO2CH3 when X2 is OX1; X3 is selected from OR1, where R1 is as defined, CN, (= O), or H; X4 is -H or C1-C18 alkyl; and X5 is selected from H, or R1 where R1 is as defined; with the exception of compounds 14 and 47. |
| priorityDate | 2000-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 250.